RSB Spine's 1,000th InterPlate product implanted

RSB Spine, LLC, today announced a 38% increase in sales for year ended Dec. 31, 2009, versus year-end 2008, and a 42% sales increase for the fourth quarter of 2009 versus third-quarter 2009. Additionally, the company reported that it achieved an important milestone in 2009 with its 1,000th InterPlate® product being implanted.

RSB Spine Chief Executive Officer John A. Redmond said: "We are obviously delighted with our strong sales performance both year over year and sequentially, which we attribute to be the direct result of the master distribution agreement signed with Paradigm BioDevices in October 2009. We are also very pleased to have achieved the significant milestone of having our products implanted in more than 1,000 patients with excellent results."